A clinical trial to study the prediction of outcome in patients with sepsis using acute phase reactants and SOFA Scoring system.
Not Applicable
- Conditions
- Health Condition 1: A30-A49- Other bacterial diseases
- Registration Number
- CTRI/2024/06/069560
- Lead Sponsor
- Dr Kajal Magnani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult males or females fulfilling qSOFA Criteria
Respiratory rate >22/min
GCS <15
SBP <100mmHg
Exclusion Criteria
1)Patients with Rheumatic Heart Disorder and Collagen Vascular Disease
2)Patients with malignancy
3)Pregnant women
4)Patients who received antibiotics in prior 7 days
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To measure the levels of serum acute phase reactants to reflect the presence and intensity of an inflammatory process in patients with sepsis <br/ ><br>Timepoint: 2 days
- Secondary Outcome Measures
Name Time Method To study the mortality in patients with sepsis by correlating the levels of acute phase reactants & SOFA SCORETimepoint: 2 days